Monopar Therapeutics's chart data is dated 2026-10-09. Recorded technical signals: MACD bullish cross. There are 5 published signal records.
Monopar Therapeutics last closed at $78.96 (-5.98%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq. Trailing 12 months PER is -40.2×. Its overall grade ranks 227 of 738 stocks in Healthcare.
About this company
Monopar Therapeutics last closed at $78.96 (-5.98%) on 2026-10-09. Signals today: MACD bullish cross. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall B+ · 227/738
Valuation grade A-
Related stocks
- AstraZenecaCompetitor
종양학·희귀질환 파이프라인에서 경쟁
- PfizerCompetitor
항암제 및 희귀질환 치료제 개발 경쟁
- Merck & Co.Competitor
면역항암·종양학 분야에서 경쟁
ETFs holding this stock
Virtus LifeSci Biotech Clinical Trials ETF
Details →About Monopar Therapeutics
- What technical signals does Monopar Therapeutics (MNPR) have?
- Monopar Therapeutics current technical signals: MACD bullish cross.
- Is Monopar Therapeutics a cup-and-handle pattern?
- No. Monopar Therapeutics has no valid Cup signal right now.
- What published figures are available for Monopar Therapeutics?
- Market cap: $527.66M. Trailing 12 months PER: -40.2×. Latest quarter PBR: 5.48×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Monopar Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.